clinical trial · NCT07708441
A Trial of HRS-1780 in Participants With Uncontrolled Hypertension or Resistant Hypertension.
Shandong Suncadia Medicine Co., Ltd.·phase3·not yet recruiting·n = 914
Uncontrolled or Resistant HypertensionHRS-1780 tabletHRS-1780 tabletHRS-1780 tabletHRS-1780 tablet placebo
brief summary
The study is being conducted to evaluate the efficacy and safety of HRS-1780 in participants with uncontrolled hypertension or resistant hypertension. To explore the optimal use of HRS-1780 in participants with uncontrolled hypertension or resistant hypertension。
started
Jul 1, 2026
primary completion
Apr 1, 2029
completion
Apr 1, 2029
last updated
Jul 16, 2026
official title
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II/III Clinical Trial to Evaluate the Efficacy and Safety of HRS-1780 in Participants With Uncontrolled Hypertension or Resistant Hypertension.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol